QurAlis Corporation
Neuro Pioneers on a Quest to Cure - QurAlis
Cambridge, United States · Founded 2016 · $135.5M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- quralis.com
- Total Funding
- $135.5M
- Last Round
- $88.0M Series BFeb 2023
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Biotechnology company developing precision medicines for ALS and neurodegenerative diseases, founded by Harvard Medical School researchers.
Summary
QurAlis Corporation is a Biotech company based in Cambridge, United States, founded in 2016. It has raised $135.5M in total across 3 rounds, most recently a $88.0M Series B round in Feb 2023. Investors include Sanofi Ventures, Droia Ventures and EQT AB.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2023
Sign up to see all 3 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/quralis-corporation"><img src="https://indexed.vc/api/badge/company/quralis-corporation" alt="QurAlis Corporation on Indexed.vc" width="260" height="76" /></a>